| Cell line name |
MA148 |
|---|
| Synonyms |
MA 148; MA-148 |
|---|
| Accession |
CVCL_AK47 |
|---|
| Resource Identification Initiative |
To cite this cell line use: MA148 (RRID:CVCL_AK47) |
|---|
| Comments |
Derived from site: In situ; Ovary; UBERON=UBERON_0000992. |
|---|
| Disease |
Ovarian cystadenocarcinoma (NCIt: C5228) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Female |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=8640821
Ramakrishnan S., Olson T.A., Bautch V.L., Dhanabal M.
Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
Cancer Res. 56:1324-1330(1996) PubMed=10786683
Yokoyama Y., Dhanabal M., Griffioen A.W., Sukhatme V.P., Ramakrishnan S.
Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
Cancer Res. 60:2190-2196(2000) PubMed=12361951; DOI=10.1074/jbc.M207937200
Donahue S.L., Campbell C.
A DNA double strand break repair defect in Fanconi anemia fibroblasts.
J. Biol. Chem. 277:46243-46247(2002) PubMed=19926575; DOI=10.1309/AJCPTK87EMMIKPFS; PMCID=PMC3040237
DeRycke M.S., Andersen J.D., Harrington K.M., Pambuccian S.E., Kalloger S.E., Boylan K.L.M., Argenta P.A., Skubitz A.P.N.
S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.
Am. J. Clin. Pathol. 132:846-856(2009) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54903894
|
|---|
| Entry history |
|---|
| Entry creation | 02-May-2016 |
|---|
| Last entry update | 29-Jun-2023 |
|---|
| Version number | 6 |
|---|
